Monte Rosa Stock Doubles — Up 127% — On A Massive Deal With Novartis
In this article:
Monte Rosa Therapeutics shares doubled Monday on a deal with Novartis to develop treatments for immune system conditions.
Advertisement
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
Monte Rosa Therapeutics shares doubled Monday on a deal with Novartis to develop treatments for immune system conditions.